Titre : méta-Aminobenzoates

méta-Aminobenzoates : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "méta-Aminobenzoates : Questions médicales les plus fréquentes", "headline": "méta-Aminobenzoates : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les méta-Aminobenzoates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-20", "dateModified": "2025-03-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "méta-Aminobenzoates" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Aminobenzoates", "url": "https://questionsmedicales.fr/mesh/D062365", "about": { "@type": "MedicalCondition", "name": "Aminobenzoates", "code": { "@type": "MedicalCode", "code": "D062365", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.127.020" } } }, "about": { "@type": "MedicalCondition", "name": "méta-Aminobenzoates", "alternateName": "meta-Aminobenzoates", "code": { "@type": "MedicalCode", "code": "D062368", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Takayuki Katoh", "url": "https://questionsmedicales.fr/author/Takayuki%20Katoh", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan." } }, { "@type": "Person", "name": "Hiroaki Suga", "url": "https://questionsmedicales.fr/author/Hiroaki%20Suga", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan." } }, { "@type": "Person", "name": "Rashmi Kumar", "url": "https://questionsmedicales.fr/author/Rashmi%20Kumar", "affiliation": { "@type": "Organization", "name": "Chemistry Department, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States." } }, { "@type": "Person", "name": "Hilkka I Kenttämaa", "url": "https://questionsmedicales.fr/author/Hilkka%20I%20Kentt%C3%A4maa", "affiliation": { "@type": "Organization", "name": "Chemistry Department, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States." } }, { "@type": "Person", "name": "Bidisha R Bora", "url": "https://questionsmedicales.fr/author/Bidisha%20R%20Bora", "affiliation": { "@type": "Organization", "name": "Applied Organic Chemistry, Chemical Sciences & Technology Division, CSIR-North East Institute of Science and Technology, Jorhat-785006, AcSIR, Ghaziabad-201002, India. skgogoi1@gmail.com sanjibgogoi@neist.res.in." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effectiveness of whole-body electromyostimulation on knee pain and physical function in knee osteoarthritis: a randomized controlled trial.", "datePublished": "2024-09-06", "url": "https://questionsmedicales.fr/article/39242729", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-71552-7" } }, { "@type": "ScholarlyArticle", "name": "Effect of Raloxifene Treatment on Apolipoproteins and Lipoprotein(a) Concentrations in Postmenopausal Women: A Meta-Analysis of Randomized Controlled Trials.", "datePublished": "2024-08-23", "url": "https://questionsmedicales.fr/article/39181829", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clinthera.2024.07.008" } }, { "@type": "ScholarlyArticle", "name": "Can Bisphosphonate Therapy Reduce Overall Mortality in Patients With Osteoporosis? A Meta-analysis of Randomized Controlled Trials.", "datePublished": "2024-08-22", "url": "https://questionsmedicales.fr/article/39172899", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/CORR.0000000000003204" } }, { "@type": "ScholarlyArticle", "name": "Analgesic effectiveness of methoxyflurane inhaler during genicular nerve block in knee osteoarthritis: a randomized controlled trial.", "datePublished": "2024-08-21", "url": "https://questionsmedicales.fr/article/39174051", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/rapm-2024-105777" } }, { "@type": "ScholarlyArticle", "name": "Comparing the hemodynamic effects of ketamine versus fentanyl bolus in patients with septic shock: a randomized controlled trial.", "datePublished": "2024-08-18", "url": "https://questionsmedicales.fr/article/39154316", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00540-024-03383-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Benzoates", "item": "https://questionsmedicales.fr/mesh/D001565" }, { "@type": "ListItem", "position": 8, "name": "Aminobenzoates", "item": "https://questionsmedicales.fr/mesh/D062365" }, { "@type": "ListItem", "position": 9, "name": "méta-Aminobenzoates", "item": "https://questionsmedicales.fr/mesh/D062368" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : méta-Aminobenzoates - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur méta-Aminobenzoates", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur méta-Aminobenzoates", "description": "Comment diagnostiquer une intoxication aux méta-Aminobenzoates ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une intoxication ?\nY a-t-il des marqueurs biologiques spécifiques ?\nComment évaluer la gravité de l'intoxication ?", "url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur méta-Aminobenzoates", "description": "Quels sont les symptômes courants des méta-Aminobenzoates ?\nLes méta-Aminobenzoates causent-ils des allergies ?\nY a-t-il des effets secondaires graves ?\nComment les symptômes varient-ils selon la dose ?\nLes symptômes sont-ils réversibles ?", "url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur méta-Aminobenzoates", "description": "Comment prévenir l'exposition aux méta-Aminobenzoates ?\nY a-t-il des réglementations sur leur utilisation ?\nQuels conseils de sécurité pour les travailleurs ?\nLes consommateurs doivent-ils être informés ?\nComment sensibiliser le public aux risques ?", "url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur méta-Aminobenzoates", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les méta-Aminobenzoates ?\nComment gérer les réactions allergiques ?\nQuel suivi est nécessaire après traitement ?\nLes traitements sont-ils différents pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur méta-Aminobenzoates", "description": "Quelles complications peuvent survenir après une intoxication ?\nLes méta-Aminobenzoates peuvent-ils causer des cancers ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques à long terme ?\nLes complications sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur méta-Aminobenzoates", "description": "Qui est le plus à risque d'intoxication ?\nLes enfants sont-ils plus vulnérables ?\nQuels comportements augmentent le risque ?\nY a-t-il des prédispositions génétiques ?\nLes personnes allergiques sont-elles plus à risque ?", "url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux méta-Aminobenzoates ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour détecter les niveaux de méta-Aminobenzoates." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les concentrations de méta-Aminobenzoates." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges, des éruptions cutanées et des troubles respiratoires." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques spécifiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de marqueurs biologiques spécifiques, mais des tests de toxicité peuvent aider." } }, { "@type": "Question", "name": "Comment évaluer la gravité de l'intoxication ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La gravité est évaluée par l'intensité des symptômes et les résultats des tests de laboratoire." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des méta-Aminobenzoates ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées, des éruptions cutanées et des vertiges." } }, { "@type": "Question", "name": "Les méta-Aminobenzoates causent-ils des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent provoquer des réactions allergiques, notamment des éruptions cutanées et des démangeaisons." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires graves ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires graves peuvent inclure des troubles respiratoires et des réactions anaphylactiques." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes s'aggravent généralement avec l'augmentation de la dose et la durée d'exposition." } }, { "@type": "Question", "name": "Les symptômes sont-ils réversibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des symptômes sont réversibles avec un traitement approprié et l'élimination de l'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux méta-Aminobenzoates ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant des méta-Aminobenzoates et suivez les consignes de sécurité." } }, { "@type": "Question", "name": "Y a-t-il des réglementations sur leur utilisation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations existent pour limiter l'utilisation des méta-Aminobenzoates dans certains produits." } }, { "@type": "Question", "name": "Quels conseils de sécurité pour les travailleurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs doivent porter des équipements de protection et suivre des protocoles de sécurité." } }, { "@type": "Question", "name": "Les consommateurs doivent-ils être informés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'étiquetage des produits doit informer les consommateurs des risques potentiels." } }, { "@type": "Question", "name": "Comment sensibiliser le public aux risques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des formations peuvent sensibiliser le public aux risques associés." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal consiste à éliminer l'exposition et à administrer des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les méta-Aminobenzoates ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, mais des traitements symptomatiques peuvent être efficaces." } }, { "@type": "Question", "name": "Comment gérer les réactions allergiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les réactions allergiques peuvent être traitées avec des antihistaminiques et des corticostéroïdes." } }, { "@type": "Question", "name": "Quel suivi est nécessaire après traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est recommandé pour surveiller les symptômes et prévenir les complications." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent varier en fonction de l'âge et du poids de l'enfant." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles respiratoires, des réactions allergiques sévères et des lésions organiques." } }, { "@type": "Question", "name": "Les méta-Aminobenzoates peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont gérées par des soins médicaux appropriés et un suivi régulier." } }, { "@type": "Question", "name": "Y a-t-il des risques à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des risques à long terme peuvent inclure des problèmes respiratoires chroniques et des allergies." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout en cas d'exposition prolongée." } }, { "@type": "Question", "name": "Qui est le plus à risque d'intoxication ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs exposés à des produits chimiques contenant des méta-Aminobenzoates sont à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus vulnérables en raison de leur taille et de leur métabolisme." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'usage inapproprié de produits chimiques et le non-respect des consignes de sécurité augmentent le risque." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines prédispositions génétiques peuvent influencer la sensibilité aux méta-Aminobenzoates." } }, { "@type": "Question", "name": "Les personnes allergiques sont-elles plus à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus susceptibles de réagir." } } ] } ] }

Sources (10000 au total)

Effect of Raloxifene Treatment on Apolipoproteins and Lipoprotein(a) Concentrations in Postmenopausal Women: A Meta-Analysis of Randomized Controlled Trials.

Although various randomized controlled trials (RCTs) have evaluated the effect of raloxifene on apolipoproteins and lipoprotein(a) concentrations in postmenopausal women, the results have been inconsi... Two independent researchers systematically searched the scientific literature (including PubMed/Medline, Scopus, Web of Science, and EMBASE) for English-language randomized controlled trials (RCTs) pu... The present meta-analysis incorporated 12 publications with 14 RCT arms. The comprehensive outcomes derived from the random-effects model revealed a statistically significant increase in ApoA-I (WMD: ... The current meta-analysis of RCTs demonstrates that treatment with raloxifene reduces ApoB and Lp(a) levels while increasing ApoA-I levels in postmenopausal women. Since these effects on lipid compone...

Can Bisphosphonate Therapy Reduce Overall Mortality in Patients With Osteoporosis? A Meta-analysis of Randomized Controlled Trials.

For patients with osteoporosis, bisphosphonate therapy can reduce the risk of fractures, but its effect on reducing mortality remains unclear. Previous studies on this topic have produced conflicting ... In a large meta-analysis of placebo-controlled randomized controlled trials (RCTs), we asked: (1) Does bisphosphonate use reduce mortality? (2) Is there a subgroup effect based on whether different bi... We conducted a systematic review using multiple databases, including Embase, Web of Science, Medline (via PubMed), Cochrane Library, and ClinicalTrials.gov, with each database searched up to November ... The use of bisphosphonates did not reduce the overall risk of mortality in patients with osteoporosis (risk ratio 0.95 [95% CI 0.88 to 1.03]). Subgroup analyses involving different bisphosphonate drug... Based on our comprehensive meta-analysis, there is high-quality evidence suggesting that bisphosphonate therapy for patients with osteoporosis does not reduce the overall risk of mortality despite its... Level I, therapeutic study....

Analgesic effectiveness of methoxyflurane inhaler during genicular nerve block in knee osteoarthritis: a randomized controlled trial.

Up to 30% of patients with knee osteoarthritis (KOA) have evidence of sensitization, with a similar proportion experiencing severe pain during procedures. Most patients with KOA are elderly and often ... 42 adults with refractory KOA were randomized into two groups. Methoxyflurane group received a self-titrated methoxyflurane inhaler with local anesthesia whereas lidocaine group received local anesthe... 42 patients with a mean age of 66±12 years participated in this study. There were no significant baseline differences. During the procedure, the methoxyflurane group experienced a significantly greate... A methoxyflurane inhaler combined with local anesthesia provided better procedural pain control than local anesthesia alone with no observable differences in adverse effects. Future studies evaluating...

Comparing the hemodynamic effects of ketamine versus fentanyl bolus in patients with septic shock: a randomized controlled trial.

Ketamine and fentanyl are commonly used for sedation and induction of anesthesia in critically ill patients. This study aimed to compare the hemodynamic effects of ketamine versus fentanyl bolus in pa... This randomized controlled trial included mechanically ventilated adults with septic shock receiving sedation. Patients were randomized to receive either 1 mg/kg ketamine bolus or 1 mcg/kg fentanyl bo... Eighty-six patients were analyzed. The median (quartiles) delta CO 6 min after drug injection was 71(37, 116)% in the ketamine group versus - 31(- 43, - 12)% in the fentanyl group, P value < 0.001. Th... In patients with septic shock, ketamine bolus was associated with higher CO and SV compared to fentanyl bolus.... Date of registration: 24/07/2023.... gov Identifier: NCT05957302. URL: https://clinicaltrials.gov/study/NCT05957302 ....

Long-term safety of tezepelumab in patients with asthma: a systematic review and meta-analysis of randomized controlled trials.

Tezepelumab has demonstrated its effectiveness in patients with asthma, but its safety, especially for long-term use, needs to be further explored. This systematic review and meta-analysis aimed to de... A systematic search was made of PubMed, Embase, Cochrane Library, and clinicaltrials.gov, without language restrictions.... Randomized controlled trials (RCTs) on treatment of asthma with tezepelumab, compared with placebo, were reviewed. Studies were pooled to weighted mean differences (WMDs) and risk ratios (RRs), with 9... Seven RCTs (enrolling 2050 participants) met the inclusion criteria. Serious adverse event (RR 0.74, 95% CI 0.57 to 0.95), upper respiratory tract infection (RR 0.73, 95% CI 0.55 to 0.96), and asthma ... Long-term (12-52 wk) use of tezepelumab in patients with asthma does not increase the incidence of adverse events....

The effect of perineural dexamethasone on nerve injury and recovery of nerve function after surgery: A randomized controlled trial.

While numerous studies have examined the influence of perineural dexamethasone on nerve block duration, its potential impact on postoperative nerve injury has not been adequately addressed.... This study aims to elucidate the effect of perineural dexamethasone on nerve injury and nerve function recovery after surgery.... A prospective randomized double-blinded trial.... The First Affiliated Hospital of Chengdu Medical College, Chengdu, China. The study was conducted between 14 June and 30 December 2022.... Patients aged 18 - 80 years, ASA I - II, scheduled for elective orthopedic or burn and plastic surgery.... Patients were randomized to receive either perineural dexamethasone (D group) or no dexamethasone (ND group).... Primary outcomes were the incidence and recovery of nerve injury. Secondary outcomes included postoperative pain scores, analgesic consumption, and adverse events.... Initial postoperative nerve injury rates were similar between groups (D: 30.4 %, ND: 33.3 %, P > 0.05). At 12 weeks post-discharge, significantly more patients in the ND group recovered from nerve def... Perineural dexamethasone may impede nerve function recovery, suggesting caution in its use, particularly for patients with pre-existing nerve damage or diabetes. Further research is needed to elucidat... chictr.org.cn, ChiCTR2200059424....